Filing Details
- Accession Number:
- 0001179110-12-016846
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-04 16:06:35
- Reporting Period:
- 2012-12-03
- Filing Date:
- 2012-12-04
- Accepted Time:
- 2012-12-04 16:06:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1274792 | Merrimack Pharmaceuticals Inc | MACK | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1531962 | B. Ulrik Nielsen | C/O Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 | Svp And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-12-03 | 75,000 | $7.37 | 176,811 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.495, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Billionaire Hedge Funds
